“N-ras Gene Point Mutations in Brazilian Acute Myelogenous Leukemia Patients Correlate with a Poor Prognosiss”

References

• Barbacid M. ras genes. Ann. Rev, Biochem. 1987; 56: 779–827
   PubMed Web of Science ®Google Scholar
• Kastan M. B., Strauss L. C., Civin C. I. The role of hematopoietic growth factors and oncogenes in leukemogenesis. Am. J. Pediatr. Hematol. Oncol. 1989; 11: 249–267
   PubMed Web of Science ®Google Scholar
• McKenzie S. J. Diagnostic utility of oncogenes and their products in human cancer. Biochim. Biophys. Acta. 1991; 1072: 193–214
   PubMed Web of Science ®Google Scholar
• Haubruck H., McCormick F. ras p21: effects and regulation. Biochim. Biophys. Acta. 1991; 1072: 215–229
   PubMed Web of Science ®Google Scholar
• Barbacid M. ras oncogenes: their role in neoplasia. Eur. J. Clin. Inv. 1990; 20: 225–235
   PubMed Web of Science ®Google Scholar
• Chang E. H., Miller P. S., Cushman C., Devadas K., Piroilo K. F., Ts'o P. O., Yu Z. P. Antisense inhibition of ras p21 expression that is sensitive to a point mutation. Biochemistry 1991; 30: 8283–8286
   PubMed Web of Science ®Google Scholar
• Bos J. L., Toksoz D., Marshall C. J., Verlaan‐de Vries M., Veeneman G. H., van der Eb A. J., van Boom J. H., Janssen J. W., Steenvoorden A. C. Amino‐acid substitutions at codon 13 of the N‐ras oncogene in human acute myeloid leukaemia. Nature 1985; 315: 726–730
   PubMed Web of Science ®Google Scholar
• Lubbert M., Mirro J., Jr., Miller C. W., Kahan J., Isaac G., Kitchingman C., Mertelsmann R., Herrman F., McCormick F., Koeffler H. P. N‐ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. Blood 1990; 75: 1163–1169
   PubMed Web of Science ®Google Scholar
• Janssen J. W. G., Steenvoorden A. C. M., Lyons J., Anger B., Böhlke J. U., Bos J. L., Seliger H., Bartram C. R. ras gene mutations in acute and chronic myelocitic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes. Proc. Natl. Acad. Sci. USA 1987; 84: 9228–9232
   PubMed Web of Science ®Google Scholar
• Radich J. P., Kopecky K. J., Willman C. L., Weick J., Head D., Appelbaun F., Collins S. J. N‐ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. Blood 1990; 76: 801–807
   PubMed Web of Science ®Google Scholar
• Neubauer A., Dodge R. K., George S. L., Davey F. R., Silver R. T., Schiffer C. A., Mayer R. J., Ball E. D., Wuster‐Hill D., Bloomfield C. D., Liu E. T. Prognostic importance of mutations in the ras proto‐oncogenes in de novo acute myeloid leukemia. Blood 1994; 83: 1603–1611
   PubMed Web of Science ®Google Scholar
• Padua R. A., Carter G., Hughes D., Gow J., Farr C., Oscier D., McCormick F., Jacobs A. ras mutations in myelodysplasia detected by amplification, oligonucleotide hybridization, and transformation. Leukemia 1988; 2: 503–510
   PubMed Web of Science ®Google Scholar
• Taylor J. A., Sandler D. P., Bloomfield C. D., Shore D. L., Ball E. D., Neubauer A., McIntyre O. R., Liu E. ras oncogene activation and occupational exposures in acute myeloid leukemia. J. Natl. Cancer Inst. 1992; 84: 1626–1632
   PubMed Web of Science ®Google Scholar
• Melo M. B., Sales T. S. I., Lorand‐Metze I., Costa F. F. Rapid method for isolation of DNA from glass slide smears for PCR. Acta Haematol. 1992; 87: 214–215
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for classification of the acute leukaemia French‐American‐British (FAB) Cooperative Group. Br. J. Haematol. 1976; 33: 451458
   Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7): a report of the French‐American‐British Cooperative Group. Ann. Int. Med. 1985; 103: 460–462
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French‐American‐British Cooperative Group. Ann. Int. Med. 1985; 103: 626–629
   PubMedGoogle Scholar
• Yunis J. J. New Chromosome techniques in the study of human neoplasia. Human Pathol. 1981; 12: 540–549
   PubMed Web of Science ®Google Scholar
• Testa J. R., Rowley J. D. Chromosomes in leukemia and lymphoma with special emphasis on methodology. The leukemia cell, D. Catovsky. Churchill‐Livingstone, Edinburg 1980; 184
   Google Scholar
• ISNC. Guidelines for cancer cytogenetics, supplement to an International System for Human Cytogenetic Nomenclature, F. Mitelman. S. Karger, Basel 1991
   Google Scholar
• Büchner T., Hiddeman W., Loffler G., Gassmann W., Maschmeyer G., Heit W., Hossfeld D., Weh H., Ludwig W. D., Thiel E., Nowrousian M., Aul C., Lengfelder E., Lathan B., Mainzer K., Urbanitz D., Emmerich B., Middelhoff G., Donhuijsen‐Ant H. R., Hellriegel H. P., Heinecke A. Improved cure rate by very early intensification combined with prolonged maintenance chemotherapy in patients with acute myeloid leukemia: data from the AML Cooperative Group. Seminars Hematol. 1991; 28: 76–79
   PubMed Web of Science ®Google Scholar
• Wahlin A., Homsten P., Jonsson H. Remission rate and survival in acute myeloid leukemia: impact of selection and chemotherapy. Eur. J. Haematol. 1991; 46: 240–247
   PubMed Web of Science ®Google Scholar
• Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning, a Laboratory Manual2nd ed. Cold Spring Harbor, New York 1989
   Google Scholar
• Saiki R. K., Gelfand D. H., Stoffel S., Scharf S. J., Higushi R., Horn G. T., Mullis K. B., Erlich H. A. Primer‐directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487–491
   PubMed Web of Science ®Google Scholar
• Costa F. F., Figueiredo M. S., Sonati M. F., Kimura E. M., Martins C. S. B. The IVS 1–110 and codon 39 beta thalassemia mutations in association with alpha tha12 (‐37 Kb) and Hb Hasharon in a Brazilian patient. Hemoglobin 1992; 16: 525–528
   PubMed Web of Science ®Google Scholar
• Lyons J., Janssen J. W. G., Bartram C., Layton M., Mufti G. J. Mutation of N‐ras and N‐ras oncogenes in myelodysplastic syndromes. Blood 1988; 71: 1707–1712
   PubMed Web of Science ®Google Scholar
• Miranda S. R. P., Gonçalves M. S., Sonati M. F., Saad S. T. O., Costa F. F. Rapid identification of beta‐globin strutural variants by sequencing the mRNA from peripheral blood retyculocytes. Bruz. J. Med. Biol. Rex 1993; 26: 1025–1030
   PubMed Web of Science ®Google Scholar
• Wilcoxon F. Individual comparison by ranking methods. Biometrics 1945; 1: 80–83
   Web of Science ®Google Scholar
• Mann H. B., Whitney D. R. On a test of whether one of two random variables is stochastically larger than the other. Ann. Muth. Statist. 1947; 18: 50–60
   Google Scholar
• Fisher R. A. Statistical methods for research workers, Oliver, Boyd. Edinburgh. 1934
   Google Scholar
• Gehan E. A. A generalized two sample Wilcoxon test for doubly‐censored data. Biometrika 1965; 52: 650–653
   PubMed Web of Science ®Google Scholar
• Gehan E. A. A generalized Wilcoxon test for comparing arbitrarily singly‐censored samples. Biometrika 1965; 52: 203–223
   PubMed Web of Science ®Google Scholar
• Smit V. T. H. B. M., Boot A. J. M., Smits A. M. M., Fleuren G. J., Cornelisse C. J., Bos J. L. K‐ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res. 1988; 16: 7773–7783
   PubMed Web of Science ®Google Scholar
• Rodenhuis S., Slebos R. J., Boot A. J. M., Evers S. G., Mooi W. J., Wagenaar S. S., van Bodegon P. C., Bos J. L. Incidence and possible clinical significance of K‐ras oncogene activation in adenocarcinoma of the human lung. Cancer Res. 1988; 48: 5738–5741
   PubMed Web of Science ®Google Scholar
• Suzuki Y., Orita M., Shiraishi M., Hayashi K., Sekiya T. Detection of ras gene mutations in human lung cancers by single‐strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 1990; 5: 1037–1043
   PubMed Web of Science ®Google Scholar
• Lemoine N. R., Mayall E. S., Wyllie F. S., Farr C. J., Hughes D., Padua R. A., Thurston V., Williams E. D., Wynford‐Thomas D. Activated ras oncogenes in human thyroid cancers. Cancer Res. 1988; 48: 4459–4463
   PubMed Web of Science ®Google Scholar
• Bos J. L., Fearon E. R., Hamilton S. R., Verlaan‐de Vries M., van Boom J. H., van der EB A. J., Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987; 327: 293–297
   PubMed Web of Science ®Google Scholar
• Forrester K., Almoguera C., Han K., Grizzle W. E., Perucho M. Detection of high incidence of K‐ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298–303
   PubMed Web of Science ®Google Scholar
• Senn H. P., Tran‐Thang C., Wodnar‐Filipowicz A., Jiricny J., Fopp M., Gratwohl A., Signer E., Weber W., Moroni C. Mutation analysis of the N‐ras proto‐oncogene in active and remission phase of human acute leukemias. Int. J. Cancer 1988; 41: 59–64
   PubMed Web of Science ®Google Scholar
• Farr C., Gill R., Katz F., Gibbons B., Marshall C. Analysis of ras gene mutations in childhood myeloid leukaemia. Br. J. Haematol. 1991; 77: 323–327
   PubMed Web of Science ®Google Scholar
• Ahuja H. G., Foti A., Bar‐Eli M., Cline M. J. The pattern of mutational involvement of ras genes in human hematologic malignancies determined by DNA amplification and direct sequencing. Blood 1990; 75: 1684–1690
   PubMed Web of Science ®Google Scholar
• Chin I. Y., Koh C., Bosco J. L. ras gene mutations in Malaysian leukemia patients. Acta Haematol. 1992; 87: 107–108
   PubMed Web of Science ®Google Scholar
• van Mansfeld A. D. M., Bos J. L. PCR‐based approaches for detection of mutated ras genes. PCR Methods and Applications 1992; 1: 211–216
   PubMedGoogle Scholar
• Bos J. L., Verlaan‐de Vries M., van der Eb A. J., Janssen J. W. G., Delwel R., Lowenberg B., Colly L. P. Mutations in N‐ras predominate in acute myeloid leukemia. Blood 1987; 69: 1237–1241
   PubMed Web of Science ®Google Scholar
• Browett P. J., Norton J. D. Analysis of ras gene mutations and methylation state in human leukemias. Oncogene 1989; 4: 1029–1036
   PubMed Web of Science ®Google Scholar
• Lorand I. G. H., Souza C. A., Costa F. F. Hematological toxicity associated with agricultural chemicals. Lancet 1984; 1: 404
   PubMed Web of Science ®Google Scholar
• Fax C. J., Saiki R. K., Erlich H. A., McCormick F., Marshall C. J. Analysis of ras gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes. Proc. Natl. Acad. Sci. USA 1988; 85: 1629–1633
   PubMed Web of Science ®Google Scholar
• Bartram C. R., Ludwig W. D., Hiddeman W., Lyons J., Buschle M., Ritter J., Harbott J., Frohlic A., Janssen J. W. Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X‐linked loci. Leukemia. 1989; 3: 247–256
   PubMed Web of Science ®Google Scholar